InvestorsHub Logo
Followers 230
Posts 21522
Boards Moderated 2
Alias Born 08/03/2006

Re: farrell90 post# 221896

Wednesday, 03/21/2018 1:35:55 PM

Wednesday, March 21, 2018 1:35:55 PM

Post# of 403591
Quite possible. I think the light bulbs really came on during the last trial.

Successful trial it was. The goal all along has been to create the oral form.

Thanks Farrell90.

Message in reply to:

IPIX announced in 12/2016 it had engaged a CRO to begin preliminary lab testing for oral Kevetrin.

"On the basis of these results, Cellceutix has now selected CROs to perform the additional nonclinical studies, including necessary bridging toxicology, required to support clinical dosing of Kevetrin via the oral route. Additional laboratory research is underway to further expand these findings."

It is possible they are further along with these necessary studies than most believe.

Farrell

http://www.ipharminc.com/press-release/2016/12/14/p87o1t8af2wn9fxtnapze33i3z6z29


"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News